IFP Advisors’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$96.1K Buy
1,749
+1,631
+1,382% +$89.7K ﹤0.01% 1660
2025
Q1
$8.34K Sell
118
-4,013
-97% -$284K ﹤0.01% 2643
2024
Q4
$272K Buy
4,131
+1,777
+75% +$117K 0.01% 990
2024
Q3
$165K Sell
2,354
-189
-7% -$13.3K 0.01% 1177
2024
Q2
$209K Sell
2,543
-27
-1% -$2.22K 0.01% 1022
2024
Q1
$224K Buy
2,570
+37
+1% +$3.23K 0.01% 946
2023
Q4
$244K Buy
2,533
+865
+52% +$83.4K 0.01% 859
2023
Q3
$148K Sell
1,668
-2
-0.1% -$177 0.01% 1103
2023
Q2
$145K Sell
1,670
-31
-2% -$2.69K 0.01% 1169
2023
Q1
$156K Sell
1,701
-163
-9% -$15K 0.01% 1049
2022
Q4
$175K Sell
1,864
-84
-4% -$7.89K ﹤0.01% 1423
2022
Q3
$181K Buy
1,948
+227
+13% +$21.1K ﹤0.01% 1471
2022
Q2
$160K Hold
1,721
0.01% 1410
2022
Q1
$160K Buy
1,721
+1,630
+1,791% +$152K 0.01% 1410
2021
Q4
$8K Sell
91
-16
-15% -$1.41K ﹤0.01% 2249
2021
Q3
$8K Sell
107
-2,200
-95% -$164K ﹤0.01% 2304
2021
Q2
$193K Sell
2,307
-9
-0.4% -$753 ﹤0.01% 923
2021
Q1
$175K Buy
2,316
+277
+14% +$20.9K ﹤0.01% 900
2020
Q4
$179K Buy
2,039
+122
+6% +$10.7K 0.01% 847
2020
Q3
$143K Buy
1,917
+581
+43% +$43.3K 0.01% 831
2020
Q2
$163K Sell
1,336
-127
-9% -$15.5K 0.01% 747
2020
Q1
$122K Buy
1,463
+406
+38% +$33.9K 0.01% 745
2019
Q4
$91K Sell
1,057
-23
-2% -$1.98K 0.01% 991
2019
Q3
$76K Buy
+1,080
New +$76K 0.01% 1188
2019
Q1
$2K Sell
19
-203
-91% -$21.4K ﹤0.01% 2066
2018
Q4
$19K Buy
222
+71
+47% +$6.08K ﹤0.01% 2132
2018
Q3
$15K Sell
151
-108
-42% -$10.7K ﹤0.01% 2582
2018
Q2
$24K Buy
259
+125
+93% +$11.6K ﹤0.01% 2320
2018
Q1
$12K Hold
134
﹤0.01% 2664
2017
Q4
$12K Sell
134
-383
-74% -$34.3K ﹤0.01% 2660
2017
Q3
$48K Sell
517
-4
-0.8% -$371 ﹤0.01% 1995
2017
Q2
$47K Buy
521
+62
+14% +$5.59K ﹤0.01% 1989
2017
Q1
$40K Sell
459
-25
-5% -$2.18K ﹤0.01% 2033
2016
Q4
$40K Buy
484
+15
+3% +$1.24K ﹤0.01% 2000
2016
Q3
$43K Sell
469
-78
-14% -$7.15K ﹤0.01% 1894
2016
Q2
$43K Buy
547
+528
+2,779% +$41.5K ﹤0.01% 1850
2016
Q1
$2K Sell
19
-394
-95% -$41.5K ﹤0.01% 2066
2015
Q4
$43K Buy
+413
New +$43K ﹤0.01% 1693